In a B16-FAP melanoma model, we found that FAP-IL2v treatment increased CD8+ T cell and NK cell infiltration, which may partly explain the increased tumor uptake of VAP-1-targeted [68Ga]Ga-DOTA-Siglec-9. The gene discussed is CD8A; the disease is melanoma.